quired 1 ml of sample [C/in. Chem. 21, 1038 [C/in. Chem. 21, (1975 ]. The selectivity of the nitrogen detector allows a simplified extraction procedure. Between-run precision (CV) is 2.8% at a theophylline concentration of 14.8 mg/liter.
AddItional Keyphrases: theophylline in saliva, serum, plasma pediatric chemistry #{149} therapy for asthma and for apnea, bradycardia in the newborn #{149} nitrogen/phosphorus detector #{149} interference from evacuated blood-collection tubes
During the past year, several new methods have appeared for determining theophylline in biological fluids by gas chromatography or high-pressure liquid chromatography (1) (2) (3) (4) . The usefulness of monitoring serum theophylline concentration in the management of patients with asthma has been well established.
More recently, it has been demonstrated that theophylline is effective in the treatment of apnea and bradycardia of the low-birth-weight infant (5). Safe and effective use of theophylline in this context also depends on information obtained from measuring the concentrations of this drug in the serum. We describe a new gas-chromatographic procedure for theophylline, with use of a nitrogen/phosphorus detector.
The sensitivity of this detector allows the assay to be performed on sample volumes of 20 tl; its selectivity allows simplified sample preparation.
Materials and Methods

Chemicals
Theophylline, theobromine, phenobarbital, caffeine, and hypoxanthine were from Sigma Chemical Co., St. Louis, Mo. 63178. Xanthine, and 
Results and Discussion
At first, we used the micro-alkylation procedure of
Greeley (6) To further characterize this interfering peak, 2 ml of the sodium chloride solution was added to a Vacutainer, mixed well, and 20 l removed.
This sample was extracted with chloroform/isopropanol, according to our procedure.
The extract was evaporated and the residue was dissolved in 20 tl of hexane. The solution was analyzed further by gas-chromatography with the PerkinElmer nitrogen/phosphorus detector in the phosphorus mode and by gas chromatography/mass spectrometry. was added after extraction. The recovery so measured was 82%. Figure 3 illustrates a typical standard curve obtained by our procedure.
The ratio of the peak height of theophylline to the peak height of the internal standard was linearly related to concentration up to 20 mg/liter in serum. If recovery was 100% at all steps in our procedure, the 20 mg/liter standard would correspond to the on-column injection of 40 ng of theophylline.
The within-run coefficient of variation (CV) of the assay at 14.8 mg of theophylline per liter was 2.1% (n = 10), and 4.4% at 0.5 mg/liter (n = 12). Assessed during three months, between-run precision at 14.8 mg/liter was 2.8% (n = 20). Although a complete standard curve was included with each analytical run from which our overall precision data was derived, we found that the absolute variation in relative peak-height ratios of the 10 mg/liter standard and the above control plasma were only 2.3% and 2.9%, respectively.
These data demon- Extracted plasma standards were used to determine both salivary and plasma theophyllmne concentrations, because equivalent amounts of theophylline added to and extracted from both saliva and plasma gave the same relative peak-height ratios. pounds results from their ability to produce cyan radicals when burned in the detector.
The major advantage of our procedure for theophylline is that it requires a smaller sample. Our previous flame ionization gas-chromatographic procedure (2) for this drug required a 1-ml sample of serum or saliva; the present procedure requires only 20 tl, a sample size that is particularly appropriate for monitoring serum concentrations of theophylline in (e.g.) management of apnea in premature infants (5 
